Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel mouse model of prostate cancer to evaluate chemopreventive potential of pterostilbene

July 20, 2020

SMYD3 could be a potential therapeutic target in HNSCC

July 20, 2020

Expansion of phase I study evaluating eprenetapopt in TP53-mutant AML

July 17, 2020

Bcl-2/Bcl-xl dual inhibitor AZD-0466 shows promise for treating ALL

July 17, 2020

SPRY1 targeting useful for treating BRAF V600-mutant cutaneous melanoma

July 17, 2020

Nexys Therapeutics presents new ALK5 inhibitors

July 17, 2020

BPI-28592, a novel potent next-generation TRK kinase inhibitor

July 17, 2020

c-Myc overexpression used to create mouse-derived allograft model of hepatocellular carcinoma

July 17, 2020

CS-3003, an HDAC6 inhibitor, shows promise for treating multiple myeloma

July 16, 2020

Novocure and MSD to study Tumor Treating Fields with Keytruda in NSCLC

July 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...